Brookemont Capital Inc.

March 24, 2014 03:01 ET

Brookemont Evaluating Agriculture, Medical, Pharmaceutical, Resources and Real Estate Opportunities

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2014) - Brookemont Capital Inc. ("BKT", "Brookemont" or the "Company") (TSX VENTURE:BKT)(PINKSHEETS:BKTPF)(FRANKFURT:BRO) wishes to announce that management will be actively pursuing additional corporate growth drivers. The new areas that will be investigated will potentially include, but will not be limited to, agriculture, medical, pharmaceutical, resources and real estate. At this time no new project has been contemplated and there is no guarantee that one will be completed.

Conrad Clemiss, president of Brookemont states, "We are constantly looking for projects that may increase shareholder value, and given the recent excitement generated within specific sectors such as medical marihuana, we would be not doing our job as if we did not look into a variety of projects that may help build BKT's assets."

Brookemont has several ongoing projects including: a) a 100% interest in the "Albany East" Prospect. This land is prospective for hydrothermal (vein) graphite and directly borders Zenyatta Ventures Ltd. property that hosts its hydrothermal graphite deposit; b) a 100-per-cent interest in the Kenagami hydrothermal graphite prospect in Ontario; and c) an aluminous clay and rare earth prospect in the Gaspe Bay Region of Quebec, which directly borders the Grand-Vallée Deposit of Orbite Aluminae Inc.

If you would like to be added the BKT email list please send an email to

Neither the TSX Venture Exchange Inc. nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange Inc.) accepts responsibility for the adequacy or accuracy of this press release.

Contact Information